Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (2 trials)
interferon alpha-2b (Intron-A) (2 trials)
retifanlimab (Zynyz) (1 trial)
sv-br-1-gm (2 trials)
briavax (1 trial)
epacadostat (1 trial)
incmga00012 (1 trial)
Breast Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (7 total)